Grufity logo
Grufity logo

Latest Foresite Capital Management IV, LLC Stock Portfolio

$290Million | No. of Holdings #6

About Foresite Capital Management IV, LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Foresite Capital Management IV, LLC reported an equity portfolio of $290.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Foresite Capital Management IV, LLC are PHVS, CYTK, . The fund has invested 57% of it's portfolio in PHARVARIS N.V. and 21% of portfolio in CYTOKINETICS INC. <br><br> The fund managers got completely rid off LYELL IMMUNOPHARMA, INC. (LYEL), ALECTOR, INC. (ALEC) and MAZE THERAPEUTICS, INC. stocks. Foresite Capital Management IV, LLC opened new stock positions in CRINETICS PHARMACEUTICALS, INC. (CRNX). The fund showed a lot of confidence in some stocks as they added substantially to CYTOKINETICS INC (CYTK) and RELAY THERAPEUTICS, INC. (RLAY).
Foresite Capital Management IV, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$290Million
  as of Aug 14, 2026

Foresite Capital Management IV, LLC Annual Return Estimates Vs S&P 500

  • Performance

New Buys

Ticker$ Bought
crinetics pharmaceuticals, inc.5,613,000
New stocks bought by Foresite Capital Management IV, LLC

Additions

Ticker% Inc.
cytokinetics inc42.00
relay therapeutics, inc.25.00
Additions to existing portfolio by Foresite Capital Management IV, LLC

Reductions

None of the existing positions were reduced by Foresite Capital Management IV, LLC

Sold off

Ticker$ Sold
alector, inc.-8,357,480
lyell immunopharma, inc.-16,056,000
maze therapeutics, inc.-4,683,500
Foresite Capital Management IV, LLC got rid off the above stocks

Sector Distribution

  • Others
  • Healthcare
Sector%
Others65.7
Healthcare34.3

Market Cap. Distribution

  • UNALLOCATED
  • MID-CAP
Category%
UNALLOCATED65.7
MID-CAP34.3

Stocks belong to which Index?

  • Others
  • RUSSELL 2000
Index%
Others69
RUSSELL 200031
Top 5 Winners (%)%
RLAY
relay therapeutics, inc.
72.8 %
CYTK
cytokinetics inc
23.9 %
eikon therapeutics, inc.
23.4 %
PHVS
pharvaris n.v.
22.4 %
XENE
xenon pharmaceuticals inc.
3.8 %
Top 5 Winners ($)$
PHVS
pharvaris n.v.
30.2 M
CYTK
cytokinetics inc
11.7 M
RLAY
relay therapeutics, inc.
9.9 M
eikon therapeutics, inc.
4.8 M
XENE
xenon pharmaceuticals inc.
0.4 M
Top 5 Losers (%)%
Top 5 Losers ($)$

Foresite Capital Management IV, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Foresite Capital Management IV, LLC

$290.15MTotal Value
9.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Foresite Capital Management IV, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
PHVS
Pharvaris N.V.

Pharvaris N.V.

PHVS
Foresite Capital Management IV, LLC's holding in Pharvaris N.V. over time
56.95%4,778,580
$165.24M
56.95%
unchanged 0 percentunchanged
Com
Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc.

Foresite Capital Management IV, LLC's holding in Eikon Therapeutics, Inc. over time
8.74%1,943,680
$25.36M
8.74%
unchanged 0 percentunchanged
Com
Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

Foresite Capital Management IV, LLC's holding in Maze Therapeutics, Inc. over time
0%0.00
$0.00
0%
decreased 100 percentsold off